Table 1.
Validation of clinical milestones
| ACLR (n = 57) | ACLR + R (n = 18) | |||
|---|---|---|---|---|
| Effusion (trace) | Week 13 | Week 13 | ||
| Active knee extension | Week 2 | Week 1 | ||
| Passive knee extension | Week 1 | Week 2 | ||
| KOS-ADLS >80% | Week 13 | Week 11 | ||
| BPTB (n = 19) | Hamstring/Allograft (n = 38) | BPTB (n = 5) | Hamstring/Allograft (n = 13) | |
| QI >80% | Week 12-14 | Week 9 | Week 16-20 | Week 12 |
| QI >90% | Week 30 | Week 15 | Week 26-35 | Week 13 |
ACLR, anterior cruciate ligament reconstruction with or without meniscectomy; ACLR + R, anterior cruciate ligament reconstruction with meniscal repair; BPTB, bone–patellar tendon–bone graft; KOS-ADLS, Knee Outcome Survey–Activities of Daily Living Scale; QI, quadriceps strength index; Week = mean timeline of achieved milestone.